These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 32697005)

  • 21. Oral manifestations of Covid-19-A literature review.
    Farid H; Khan M; Jamal S; Ghafoor R
    Rev Med Virol; 2022 Jan; 32(1):e2248. PubMed ID: 34028129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral manifestations and the role of the oral healthcare workers in COVID-19.
    Di Spirito F; Pelella S; Argentino S; Sisalli L; Sbordone L
    Oral Dis; 2022 Apr; 28 Suppl 1():1003-1004. PubMed ID: 33084209
    [No Abstract]   [Full Text] [Related]  

  • 23. Is SARS-CoV-2 an Etiologic Agent or Predisposing Factor for Oral Lesions in COVID-19 Patients? A Concise Review of Reported Cases in the Literature.
    Etemad-Moghadam S; Alaeddini M
    Int J Dent; 2021; 2021():6648082. PubMed ID: 34054961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Could the oral cavity be a target organ in SARS-CoV-2 infection?
    Kumar S
    Evid Based Dent; 2021 Jan; 22(2):78-79. PubMed ID: 34172916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19.
    Gherlone EF; Polizzi E; Tetè G; De Lorenzo R; Magnaghi C; Rovere Querini P; Ciceri F
    J Dent Res; 2021 May; 100(5):464-471. PubMed ID: 33655804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ?
    Brandão TB; Gueiros LA; Melo TS; Prado-Ribeiro AC; Nesrallah ACFA; Prado GVB; Santos-Silva AR; Migliorati CA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Feb; 131(2):e45-e51. PubMed ID: 32888876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could dentists be the first to diagnose COVID-19 due to oral manifestations?
    Coll Y; Elmahgoub F
    Evid Based Dent; 2021 Jan; 22(2):49. PubMed ID: 34172901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Managing COVID-19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid-sparing Immunosuppression.
    Johnson KM; Belfer JJ; Peterson GR; Boelkins MR; Dumkow LE
    Pharmacotherapy; 2020 Jun; 40(6):517-524. PubMed ID: 32339304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopathogenesis of COVID-19: Summary and Possible Interventions.
    Jacques FH; Apedaile E
    Front Immunol; 2020; 11():564925. PubMed ID: 33072103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral mucosal lesions in patients with COVID-19: a systematic review.
    Bhujel N; Zaheer K; Singh RP
    Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1024-1030. PubMed ID: 34563354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of direct association between oral mucosal lesions and SARS-CoV- 2 in a cohort of patients hospitalised with COVID-19.
    Schwab G; Palmieri M; Zerbinati RM; Sarmento DJS; Reis T; Ortega KL; Kano IT; Caixeta RAV; Hasséus B; Sapkota D; Junges R; Giannecchini S; Costa ALF; Jales SMCP; Lindoso JAL; Gallo CB; Braz-Silva PH
    J Oral Microbiol; 2022; 14(1):2047491. PubMed ID: 35295979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review.
    Akhtar N; Khurshid Wani A; Kant Tripathi S; Prakash A; Amin-Ul Mannan M
    Curr Res Biotechnol; 2022; 4():337-349. PubMed ID: 35942223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral Manifestations in Patients with COVID-19: A 6-Month Update.
    Amorim Dos Santos J; Normando AGC; Carvalho da Silva RL; Acevedo AC; De Luca Canto G; Sugaya N; Santos-Silva AR; Guerra ENS
    J Dent Res; 2021 Nov; 100(12):1321-1329. PubMed ID: 34324825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cutaneous Manifestations Associated with COVID-19: A Narrative Review].
    Relvas M; Calvão J; Oliveira R; Cardoso JC; Gonçalo M
    Acta Med Port; 2021 Feb; 34(2):128-136. PubMed ID: 33315008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orofacial Mycoses in Coronavirus Disease-2019 (COVID-19): A Systematic Review.
    Samaranayake LP; Fakhruddin KS; Ngo HC; Bandara HMNM; Leung YY
    Int Dent J; 2022 Oct; 72(5):607-620. PubMed ID: 35367044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orofacial manifestations of COVID-19: a brief review of the published literature.
    Halboub E; Al-Maweri SA; Alanazi RH; Qaid NM; Abdulrab S
    Braz Oral Res; 2020; 34():e124. PubMed ID: 33146320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral lesions associated with COVID-19: A systematic review.
    Uzêda-E-Silva VD; de Sá IB; Martins J; Pedreira N; Vieira VPS; Silva BHM
    Stomatologija; 2021; 23(1):3-8. PubMed ID: 34528901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-specific oral and cutaneous manifestations of Coronavirus Disease 2019 in children.
    Bardellini E; Bondioni MP; Amadori F; Veneri F; Lougaris V; Meini A; Plebani A; Majorana A
    Med Oral Patol Oral Cir Bucal; 2021 Sep; 26(5):e549-e553. PubMed ID: 33772567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed Infections (Mucormycosis, Actinomycosis and Candidiasis) Leading to Maxillary Osteomyelitis in a Diabetic Mellitus Patient in Post COVID Phase: First Case Report.
    Jawanda MK; Narula R; Gupta S; Sharma V; Sidhu SK; Kaur N
    Acta Medica (Hradec Kralove); 2021; 64(4):218-223. PubMed ID: 35285444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurological manifestations and comorbidity associated with COVID-19: an overview.
    Kumar M; Thakur AK
    Neurol Sci; 2020 Dec; 41(12):3409-3418. PubMed ID: 33052573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.